These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3463806)

  • 1. [Retrospective serological analysis of HTLV-III/LAV antibody and immunity in hemophiliac patients in Shizuoka Prefecture].
    Mimaya J; Tonouchi T; Toyoda Y; Sugiyama T; Sonoda A; Fukuda F; Hattori T; Takatsuki K
    Rinsho Ketsueki; 1986 Jun; 27(6):866-71. PubMed ID: 3463806
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
    Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of infection by LAV/HTLV-III virus in hemophiliacs multitransfused in France. Results of a survey conducted by 28 hemophilia centers].
    Sultan Y
    Nouv Rev Fr Hematol (1978); 1986; 28(5):327-9. PubMed ID: 3643509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-LAV/HTLV III antibodies in wives of seropositive hemophilic patients].
    Bardin JM; Maisonneuve P; Nguyen M; Pinon F; Sultan Y
    Presse Med; 1986 Oct; 15(33):1686-7. PubMed ID: 2947123
    [No Abstract]   [Full Text] [Related]  

  • 6. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
    Ikegami N
    AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood products and AIDS].
    Hattori T; Koito A; Takatsuki K
    Nihon Rinsho; 1986 Oct; 44(10):2217-21. PubMed ID: 3469443
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T
    AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
    Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
    Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australian hemophiliac recipients of voluntary donor blood products longitudinally evaluated for AIDS. A clinical and laboratory study, 1983-1986.
    Garsia RJ; Gatenby PA; Basten A; Kenny DF; Gallagher KJ; Rickard KA; Gust ID; Maskill W
    Aust N Z J Med; 1987 Aug; 17(4):371-8. PubMed ID: 2963611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-HTLV-III/Lav antibodies, clinical symptoms and immunological determinations in hemophilia patients in Buenos Aires].
    Anselmo A; Muchinik G; Pérez Bianco R; de la Barrera S; Riera NE; de Bracco MM; de Tezanos Pinto M
    Medicina (B Aires); 1985; 45(3):312-3. PubMed ID: 3870213
    [No Abstract]   [Full Text] [Related]  

  • 13. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France.
    Mathez D; Leibovitch J; Sultan Y; Maisonneuve P
    N Engl J Med; 1986 Jan; 314(2):118-9. PubMed ID: 3079879
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases].
    Flepp M; Täuber MG; Lüthy R; Frauchiger B; Barandun J; Schütze M; Joller H; Frey-Wettstein M; Vetter W; Siegenthaler W
    Schweiz Med Wochenschr; 1986 Apr; 116(14):426-8. PubMed ID: 3008323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives].
    Evensen SA; Frøland SS; Glomstein A
    Tidsskr Nor Laegeforen; 1986 Jan; 106(1):19-21. PubMed ID: 3006278
    [No Abstract]   [Full Text] [Related]  

  • 17. HTLV-III antibody status and immunological abnormalities in haemophilic patients.
    Moffat EH; Bloom AL; Mortimer PP
    Lancet; 1985 Apr; 1(8434):935. PubMed ID: 2858783
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiological trends of AIDS in the United States.
    Curran JW; Morgan WM; Starcher ET; Hardy AM; Jaffe HW
    Cancer Res; 1985 Sep; 45(9 Suppl):4602s-4604s. PubMed ID: 2990692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
    Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
    Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-LAV/HTLV III antibodies in patients under hemodialysis receiving blood transfusion protocols. A retrospective study of 2 transplant centers].
    Ferec C; Deroff P; Bourbigot B; Herve JP; Le Guy P; Bignon JD; Boudard D; Soulillou JP
    Presse Med; 1986 Sep; 15(29):1378. PubMed ID: 2950422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.